Pro-inflammatory cytokine levels in postmenopausal women with the metabolic syndrome

Gynecological Endocrinology

Volumn 27, Issue 9, 2011, Pages 685-691

  Chedraui, Peter ^a   Jaramillo, Winston ^a   Pérez López, Faustino R ^b   Escobar, Gustavo S ^a   Morocho, Nancy ^a   Hidalgo, Luis ^a  

^a UNIVERSIDAD CATÓLICA DE SANTIAGO DE GUAYAQUIL   (Ecuador)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

cytokines; hypertension; interleukin 6; metabolic syndrome; obesity; Postmenopause; tumour necrosis factor

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADRENERGIC SYSTEM; ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MENOPAUSE SPECIFIC QUALITY OF LIFE; METABOLIC SYNDROME X; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL PSYCHOLOGY; TRIACYLGLYCEROL BLOOD LEVEL;

ECUADOR; FEMALE; HUMANS; INTERLEUKIN-6; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051518653     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.521270     Document Type: Article

References (59)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
2. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide classification. Lancet 2005;366:1059-1062. (Pubitemid 41338752)
3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-1645.
4. Piché ME, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes 2005;54:770-777. (Pubitemid 40322081)
5. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332-341.
6. Pérez-López FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS. Gender differences in cardiovascular disease: Hormonal and biochemical influences. Reprod Sci 2010; 17:511-531.
7. Festa A, D'Agostino RJ, Howard G, Mykkänen L, Russell PT, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47. (Pubitemid 30430551)
8. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, et al., Chronic inflammation in fat plays a crucial role in the development of obesity-relates insulin resistance. J Clin Invest 2003;112: 1821-1830. (Pubitemid 38063705)
9. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21:697-738. (Pubitemid 32113289)
10. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-809. (Pubitemid 34174919)
11. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1-16.
12. Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006; 22:447-454. (Pubitemid 44521835)
13. Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP, Poehlman ET. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002;77:128-135. (Pubitemid 34093904)
14. Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, Visser M, Houston DK, Nicklas BJ, Tylavsky FA, et al., for the Health ABC Study. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 2010, in press.
15. Sierra B, Hidalgo LA, Chedraui PA. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale. Maturitas 2005;51:236-245. (Pubitemid 40835944)
16. Castelo-Branco C, Blümel JE, Roncagliolo ME, Haya J, Bolf D, Binfa L, Tacla X, Colodrón M. Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-aged Chilean women. Maturitas 2003;45:205-212. (Pubitemid 36724876)
17. US Department of Health and Human Services, Public Health Service, National Institutes of Health (NIH). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication No. 98- 4080. Bethesda (MD): NIH; 1998.
18. Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007;56:45-53. (Pubitemid 44895637)
19. Blumel JE, Castelo-Branco C, Binfa L, Gramegna G, Tacla X, Aracena B, Cumsille MA, Sanjuan A. Quality of life after the menopause: a population study. Maturitas 2000; 34:17-23. (Pubitemid 30015983)
20. You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004;89:5517-5522. (Pubitemid 39518435)
21. Tankó LB, Christiansen C. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy. Climacteric 2006;9:169-180. (Pubitemid 43739161)
22. Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population. Cytokine 2002;19:138-146. (Pubitemid 35216194)
23. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86:515-581.
24. Cantatore FP, Loverro G, Ingrosso AM, Lacanna R, Sassanelli E, Selvaggi L, Carrozzo M. Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol 1995;14:157-160.
25. Cohen MC, Cohen S. Cytokine function: a study in biologic diversity. Am J Clin Pathol 1996;105:589-598. (Pubitemid 26152077)
26. Girasole G, Giuliani N, Modena AB, Passeri G, Pedrazzoni M. Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Clin Endocrinol (Oxf) 1990;51:801-807.
27. Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 1996;27:1009-1017. (Pubitemid 26113850)
28. Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 1997; 15:163-167. (Pubitemid 27224652)
29. Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P, Cowley AW, Hamet P. Role of tumor necrosis factor-alpha gene locus in obesity and obesityassociated hypertension in French Canadians. Hypertension 2000;36:14-19. (Pubitemid 30602146)
30. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005;12:295-300.
31. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-1804. (Pubitemid 37430249)
32. Straub RH, Hense HW, Andus T, Schö lmerich J, Riegger GA, Schunkert H. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab 2000;85:1340-1344. (Pubitemid 32269398)
33. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-214. (Pubitemid 30064452)
34. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4-12.
35. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, et al., Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008;5:e78.
36. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980-987. (Pubitemid 34920463)
37. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334. (Pubitemid 32656163)
38. Staessen JA, Wang J, Bianchi G, Birkenhager WH. Essential hypertension. Lancet 2003;361:1629-1641. (Pubitemid 36579003)
39. Vargas Alarcón G. Physiopathogenesis of hypertension. Arch Cardiol Mex 2006;76:157-160.
40. Bedi M, Varshney VP, Babbar R. Role of cardiovascular reactivity to mental stress in predicting future hypertension. Clin Exp Hypertens 2000;22:1-22. (Pubitemid 30090944)
41. Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002;52:1-23.
42. Granger JP. An emerging role for inflammatory cytokines in hypertension. Am J Physiol Heart Circ Physiol 2006;290: H923-H924.
43. Cohuet G, Struijker-Boudier H. Mechanisms of target organ damage caused by hypertension: Therapeutic potential. Pharmacol Ther 2006;111:81-98. (Pubitemid 43765539)
44. Roselló -Lletí E, Rivera M, Martínez-Dolz L, González Juanatey JR, Cortés R, Jordán A, Morillas P, Lauwers C, Calabuig JR, Antorrena I, et al., Inflammatory activation and left ventricular mass in essential hypertension. Am J Hypertens 2009;22:444-450.
45. Frossard PM, Gupta A, Pravica V, Perrey C, Hutchinson IV, Lukic ML. A study of five human cytokine genes in human essential hypertension. Mol Immunol 2002;38:969-976. (Pubitemid 34496956)
46. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin 6, and TNF-alpha) and essential hypertension. J Hum Hypertens 2005;19:149-154. (Pubitemid 40220638)
47. Lee DL, Leite R, Fleming C, Pollock JS, Webb RC, Brands MW. Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice. Hypertension 2004;44:259-263. (Pubitemid 39167220)
48. Pöyhönen-Alho MK, Manhem K, Katzman P, Kibarskis A, Antikainen RL, Erkkola RU, Tuomilehto JO, Ebeling PE, Kaaja RJ. Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. J Hypertens 2008;26:2445-2449.
49. Ferreri NR. Estrogen-TNF interactions and vascular inflammation. Am J Physiol Heart Circ Physiol 2007;292: H2566-H2569. (Pubitemid 47084505)
50. Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, Onen CL, Rangarajan S, Gerstein HC, Anand SS. Metabolic syndrome and risk of acute myocardial infarction. A casecontrol study of 26 903 subjects from 52 countries. J Am Coll Cardiol 2010;55:2390-2398.
51. The Heart Org. More evidence against concept of 'metabolic syndrome'. Available from: 1080363.do [Accessed June 30, 2010].
52. Leal Hernández M, Abellán Alemán J, Carbonell Meseguer LF, Díaz Fernández J, García Sánchez FA, Martínez Selva JM. Influence of the presence of hot flashes during menopause on the metabolism of nitric oxide. Effects of hormonal replacement treatment. Med Clin (Barc) 2000; 114:41-45. (Pubitemid 30140994)
53. Gambacciani M, Pepe A. Vasomotor symptoms and cardiovascular risk. Climacteric 2009;12(Suppl 1):32-35.
54. Chedraui P, Hidalgo L, Chavez D, Morocho N, Alvarado M, Huc A. Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch Gynecol Obstet 2007;275:161-168. (Pubitemid 46221269)
55. Pérez-López FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: Facing the post-WHI era. Fertil Steril 2009;92:1171-1188.
56. Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcification among postmenopausal women. Menopause 2010;17:256-261.
57. Noguchi M, Yuzurihara M, Kase Y, Yasui T, Irahara M. Involvement of cytokine-induced neutrophil chemoattractant in hypothalamic thermoregulation of luteinizing hormonereleasing hormone. Endocrinology 2008;149:2899-2906. (Pubitemid 351724515)
58. Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Tsuchiya N, Yuzurihara M, et al., Association of interleukin-8 with hot flashes in premenopausal, perimenopausal, and postmenopausal women and bilateral oophorectomized women. J Clin Endocrinol Metab 2006;91:4805-4808. (Pubitemid 44917311)
59. Yasui T, Maegawa M, Tomita J, Miyatani Y, Yamada M, Uemura H, Ueno S, Numata S, Ohmori T, Tsuchiya N, et al., Association of serum cytokine concentrations with psychological symptoms in midlife women. J Reprod Immunol 2007; 75:56-62. (Pubitemid 47086331)